Van Eijs et al. (van Eijs et al., 2023) hypothesize that PD-1 blockade may accelerate the progression of overt myeloid malignancies and contribute to the clonal selection of malignantly transformed progenitors. The gene discussed is PDCD1; the disease is myeloid neoplasm.